Cite Filings / RIGL
Feed Companies Filings Check
Sign in

CIK 0001034842

  • Accelerated filer

RIGEL PHARMACEUTICALS INC

Sign in to watch
Ticker
RIGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943248524
Phone
+1 650-624-1100
Business address
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
Former names
RIGEL PHARMACEUTICALS INC
Filings Financials Insiders Search text
All 1,468 Financials 363 Shareholder Meetings 30 Executive Compensation 309 Insider Trading 664 Beneficial Ownership Interest 223 Business Combinations 259 Public Offerings 85 Mutual Funds and ETFs 26 Others 126
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2009-04-15
  3. DEF 14A Proxy Proxy Statement 2008-04-08
  4. DEF 14A Proxy Proxy Statement 2007-03-26
  5. DEF 14A Proxy Proxy Statement 2006-04-25
  6. DEF 14A Proxy Proxy Statement 2005-04-27
  7. DEF 14A Proxy Proxy Statement 2004-04-29
  8. DEF 14A Proxy Proxy Statement 2003-05-19
  9. PRE 14A Proxy Proxy Statement (Preliminary) 2003-05-08
  10. DEF 14A Proxy Proxy Statement 2002-05-15
  11. DEF 14A Proxy Proxy Statement 2001-06-01

Page 2 of 2 · 30 filings

First Previous Next Last

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…